1-3 of 3
Marius Horger, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Whole-Body Reduced-Dose CT As Primary Staging and during Follow-up in First-Line Treatment of Transplant-Eligible Multiple Myeloma Patients: Results of the German GMMG-MM5 Trial

Katja Weisel, MD, Marius Horger, MD, Hartmut Goldschmidt, MD, Lothar Kanz, MD, Stefan Delorme, MD, Jens Hillengass, MD
Journal: Blood
Blood (2014) 124 (21): 3356.
https://doi.org/10.1182/blood.V124.21.3356.3356
Published: 2014
Journal Articles

Immunotherapy With RNA Vaccination Coding For TAA In Renal Cell Carcinoma: Update On Immunological Responses and Correlation With Survival

Susanne M Rittig, MD, Maik Häntschel, MD, Katrin J Weimer, MD, Annkristin Heine, MD, Martin R Müller, MD, PhD, Wolfram Brugger, MD, Marius Horger, MD, Olga Maksimovic, MD, Arnulf Stenzl, MD, Ingmar Hoerr, Hans-Georg Rammensee, Tobias A.W. Holderried, MD, Lothar Kanz, MD, Steve Pascolo, Peter Brossart, MD
Journal: Blood
Blood (2013) 122 (21): 1040.
https://doi.org/10.1182/blood.V122.21.1040.1040
Published: 2013
Journal Articles

Clinical and Radiographic Course of Bone Disease in Relapsed Multiple Myeloma in the Era of Novel Agents: Occurrence, Definition and Impact of Resclerosis Documented by Whole-Body Low-Dose Multidetector Computed Tomography

Katharina Oehrlein, MD, Marius Horger, MD, Anja Schmidt, Manola Zago, PhD, Maximilian Schulze, MD, Lothar Kanz, MD, Katja C Weisel, MD
Journal: Blood
Blood (2012) 120 (21): 3963.
https://doi.org/10.1182/blood.V120.21.3963.3963
Published: 2012